These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16670337)

  • 1. Interleukin-17 acts independently of TNF-alpha under arthritic conditions.
    Koenders MI; Lubberts E; van de Loo FA; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Kolls JK; Di Padova FE; Joosten LA; van den Berg WB
    J Immunol; 2006 May; 176(10):6262-9. PubMed ID: 16670337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis.
    Lubberts E; Joosten LA; Oppers B; van den Bersselaar L; Coenen-de Roo CJ; Kolls JK; Schwarzenberger P; van de Loo FA; van den Berg WB
    J Immunol; 2001 Jul; 167(2):1004-13. PubMed ID: 11441109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction.
    Joosten LA; Smeets RL; Koenders MI; van den Bersselaar LA; Helsen MM; Oppers-Walgreen B; Lubberts E; Iwakura Y; van de Loo FA; van den Berg WB
    Am J Pathol; 2004 Sep; 165(3):959-67. PubMed ID: 15331419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.
    Hata H; Sakaguchi N; Yoshitomi H; Iwakura Y; Sekikawa K; Azuma Y; Kanai C; Moriizumi E; Nomura T; Nakamura T; Sakaguchi S
    J Clin Invest; 2004 Aug; 114(4):582-8. PubMed ID: 15314695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis.
    Ji H; Pettit A; Ohmura K; Ortiz-Lopez A; Duchatelle V; Degott C; Gravallese E; Mathis D; Benoist C
    J Exp Med; 2002 Jul; 196(1):77-85. PubMed ID: 12093872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
    Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Di Padova FE; Boots AM; Gram H; Joosten LA; van den Berg WB
    Am J Pathol; 2005 Jul; 167(1):141-9. PubMed ID: 15972960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.
    Lubberts E; Koenders MI; van den Berg WB
    Arthritis Res Ther; 2005; 7(1):29-37. PubMed ID: 15642151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency.
    Martin P; Talabot-Ayer D; Seemayer CA; Vigne S; Lamacchia C; Rodriguez E; Finckh A; Smith DE; Gabay C; Palmer G
    Arthritis Res Ther; 2013 Jan; 15(1):R13. PubMed ID: 23324173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4.
    Canetti CA; Leung BP; Culshaw S; McInnes IB; Cunha FQ; Liew FY
    J Immunol; 2003 Jul; 171(2):1009-15. PubMed ID: 12847274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-induced structural joint damage is mediated by IL-1.
    Zwerina J; Redlich K; Polzer K; Joosten L; Krönke G; Distler J; Hess A; Pundt N; Pap T; Hoffmann O; Gasser J; Scheinecker C; Smolen JS; van den Berg W; Schett G
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11742-7. PubMed ID: 17609389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
    Lubberts E; van den Bersselaar L; Oppers-Walgreen B; Schwarzenberger P; Coenen-de Roo CJ; Kolls JK; Joosten LA; van den Berg WB
    J Immunol; 2003 Mar; 170(5):2655-62. PubMed ID: 12594294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis.
    Yamaguchi Y; Fujio K; Shoda H; Okamoto A; Tsuno NH; Takahashi K; Yamamoto K
    J Immunol; 2007 Nov; 179(10):7128-36. PubMed ID: 17982105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proinflammatory cytokine interleukin-17 and its role in pathogenesis of rheumatoid arthritis].
    Leonaviciene L; Bradūnaite R; Astrauskas V
    Medicina (Kaunas); 2004; 40(5):419-22. PubMed ID: 15170409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis.
    Vieira SM; Cunha TM; França RF; Pinto LG; Talbot J; Turato WM; Lemos HP; Lima JB; Verri WA; Almeida SC; Ferreira SH; Louzada-Junior P; Zamboni DS; Cunha FQ
    J Immunol; 2012 May; 188(10):5116-22. PubMed ID: 22491249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
    Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88.
    Joosten LA; Koenders MI; Smeets RL; Heuvelmans-Jacobs M; Helsen MM; Takeda K; Akira S; Lubberts E; van de Loo FA; van den Berg WB
    J Immunol; 2003 Dec; 171(11):6145-53. PubMed ID: 14634130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.